Literature DB >> 25644111

Neutrophil Extracellular Trap-Related Extracellular Histones Cause Vascular Necrosis in Severe GN.

Santhosh V R Kumar1, Onkar P Kulkarni1, Shrikant R Mulay1, Murthy N Darisipudi1, Simone Romoli1, Dana Thomasova1, Christina R Scherbaum1, Bernd Hohenstein2, Christian Hugo2, Susanna Müller3, Helen Liapis4, Hans-Joachim Anders5.   

Abstract

Severe GN involves local neutrophil extracellular trap (NET) formation. We hypothesized a local cytotoxic effect of NET-related histone release in necrotizing GN. In vitro, histones from calf thymus or histones released by neutrophils undergoing NETosis killed glomerular endothelial cells, podocytes, and parietal epithelial cells in a dose-dependent manner. Histone-neutralizing agents such as antihistone IgG, activated protein C, or heparin prevented this effect. Histone toxicity on glomeruli ex vivo was Toll-like receptor 2/4 dependent, and lack of TLR2/4 attenuated histone-induced renal thrombotic microangiopathy and glomerular necrosis in mice. Anti-glomerular basement membrane GN involved NET formation and vascular necrosis, whereas blocking NET formation by peptidylarginine inhibition or preemptive anti-histone IgG injection significantly reduced all aspects of GN (i.e., vascular necrosis, podocyte loss, albuminuria, cytokine induction, recruitment or activation of glomerular leukocytes, and glomerular crescent formation). To evaluate histones as a therapeutic target, mice with established GN were treated with three different histone-neutralizing agents. Anti-histone IgG, recombinant activated protein C, and heparin were equally effective in abrogating severe GN, whereas combination therapy had no additive effects. Together, these results indicate that NET-related histone release during GN elicits cytotoxic and immunostimulatory effects. Furthermore, neutralizing extracellular histones is still therapeutic when initiated in established GN.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  ARF; glomerular endothelial cells; immunology; pathology

Mesh:

Substances:

Year:  2015        PMID: 25644111      PMCID: PMC4587690          DOI: 10.1681/ASN.2014070673

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  53 in total

Review 1.  Basic and translational concepts of immune-mediated glomerular diseases.

Authors:  William G Couser
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 2.  Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.

Authors:  J Charles Jennette; Hong Xiao; Ronald J Falk
Journal:  J Am Soc Nephrol       Date:  2006-04-19       Impact factor: 10.121

Review 3.  Chromatin proteins and modifications as drug targets.

Authors:  Kristian Helin; Dashyant Dhanak
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

Review 4.  Extracellular histones in tissue injury and inflammation.

Authors:  Ramanjaneyulu Allam; Santhosh V R Kumar; Murthy N Darisipudi; Hans-Joachim Anders
Journal:  J Mol Med (Berl)       Date:  2014-04-06       Impact factor: 4.599

5.  Functional consequences of integrin-linked kinase activation in podocyte damage.

Authors:  Vicente de Paulo Castro Teixeira; Simone Monika Blattner; Min Li; Hans-Joachim Anders; Clemens David Cohen; Ilka Edenhofer; Novella Calvaresi; Monika Merkle; Maria Pia Rastaldi; Matthias Kretzler
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

6.  Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4.

Authors:  Ramanjaneyulu Allam; Christina Rebecca Scherbaum; Murthy Narayana Darisipudi; Shrikant R Mulay; Holger Hägele; Julia Lichtnekert; Jan Henrik Hagemann; Khader Valli Rupanagudi; Mi Ryu; Claudia Schwarzenberger; Bernd Hohenstein; Christian Hugo; Bernd Uhl; Christoph A Reichel; Fritz Krombach; Marc Monestier; Helen Liapis; Kristin Moreth; Liliana Schaefer; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

Review 7.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

8.  Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein.

Authors:  Maciej Lech; Alejandro Avila-Ferrufino; Ramanjaneyulu Allam; Stephan Segerer; Alexander Khandoga; Fritz Krombach; Cecilia Garlanda; Alberto Mantovani; Hans-Joachim Anders
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

9.  Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif.

Authors:  Julia Lichtnekert; Volker Vielhauer; Daniel Zecher; Onkar P Kulkarni; Sebastian Clauss; Stephan Segerer; Veit Hornung; Tanya N Mayadas; Bruce Beutler; Shizuo Akira; Hans-Joachim Anders
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

10.  Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis.

Authors:  Daigo Nakazawa; Utano Tomaru; Chiho Yamamoto; Satoshi Jodo; Akihiro Ishizu
Journal:  Front Immunol       Date:  2012-11-12       Impact factor: 7.561

View more
  68 in total

Review 1.  Necroinflammation in Kidney Disease.

Authors:  Shrikant R Mulay; Andreas Linkermann; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 10.121

2.  Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma.

Authors:  Marrah E Lachowicz-Scroggins; Eleanor M Dunican; Annabelle R Charbit; Wilfred Raymond; Mark R Looney; Michael C Peters; Erin D Gordon; Prescott G Woodruff; Emma Lefrançais; Brenda R Phillips; David T Mauger; Suzy A Comhair; Serpil C Erzurum; Mats W Johansson; Nizar N Jarjour; Andrea M Coverstone; Mario Castro; Annette T Hastie; Eugene R Bleecker; Merritt L Fajt; Sally E Wenzel; Elliot Israel; Bruce D Levy; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

Review 3.  Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.

Authors:  Beatriz Suárez-Álvarez; Helen Liapis; Hans-Joachim Anders
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

4.  Histones and Neutrophil Extracellular Traps Enhance Tubular Necrosis and Remote Organ Injury in Ischemic AKI.

Authors:  Daigo Nakazawa; Santhosh V Kumar; Julian Marschner; Jyaysi Desai; Alexander Holderied; Lukas Rath; Franziska Kraft; Yutian Lei; Yuichiro Fukasawa; Gilbert W Moeckel; Maria Lucia Angelotti; Helen Liapis; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2017-01-10       Impact factor: 10.121

Review 5.  Matters of life and death. How neutrophils die or survive along NET release and is "NETosis" = necroptosis?

Authors:  Jyaysi Desai; Shrikant R Mulay; Daigo Nakazawa; Hans-Joachim Anders
Journal:  Cell Mol Life Sci       Date:  2016-04-05       Impact factor: 9.261

6.  DNA and factor VII-activating protease protect against the cytotoxicity of histones.

Authors:  Gerben Marsman; Helen von Richthofen; Ingrid Bulder; Florea Lupu; Jan Hazelzet; Brenda M Luken; Sacha Zeerleder
Journal:  Blood Adv       Date:  2017-11-30

Review 7.  NETosis in Rheumatic Diseases.

Authors:  Mehul P Jariwala; Ronald M Laxer
Journal:  Curr Rheumatol Rep       Date:  2021-01-28       Impact factor: 4.592

8.  Lupus and proliferative nephritis are PAD4 independent in murine models.

Authors:  Rachael A Gordon; Jan M Herter; Florencia Rosetti; Allison M Campbell; Hiroshi Nishi; Michael Kashgarian; Sheldon I Bastacky; Anthony Marinov; Kevin M Nickerson; Tanya N Mayadas; Mark J Shlomchik
Journal:  JCI Insight       Date:  2017-05-18

Review 9.  Disentangling the role of neutrophil extracellular traps in rheumatic diseases.

Authors:  Yaíma L Lightfoot; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2017-01       Impact factor: 5.006

Review 10.  Neutrophils in the Pathogenesis of Rheumatic Diseases: Fueling the Fire.

Authors:  Yudong Liu; Mariana J Kaplan
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-05       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.